4.5 Review

Research progress in drug therapy of juvenile idiopathic arthritis

Journal

WORLD JOURNAL OF PEDIATRICS
Volume 18, Issue 6, Pages 383-397

Publisher

ZHEJIANG UNIV PRESS
DOI: 10.1007/s12519-022-00530-8

Keywords

Juvenile idiopathic arthritis; Progress; Treatment

Categories

Ask authors/readers for more resources

Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children. The application of biologic agents in its treatment shows significant potential and advantages.
Background Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children. With the gradual expansion of the incidence of JIA in the population, the pathogenesis and treatment of JIA were further explored and analyzed, and JIA has achieved some success in drug therapy. Data sources A systemic literature search was conducted on PubMed, Cochrane Library, EMBASE, ISI Web of Science, the US National Institutes of Health Ongoing Trials Register, and the EU Clinical Trials Register. Through the searching of clinical trials of JIA in recent years, we summarized the progress of the clinical treatment of JIA. Results The main treatment drugs for JIA include non-steroidal anti-inflammatory drugs, glucocorticoids, disease-modifying antirheumatic drugs and biological agents. So far, a variety of biological agents targeting the cytokines and receptors involved in its pathogenesis have been gradually approved for JIA in many countries. The application of biological agents in JIA showed good efficacy and safety, bringing unprecedented experience to children and adolescents with JIA. Conclusions The potential and advantages of biologic agents in the treatment of JIA are significant, and the application of biologic agents in the treatment of JIA will be more and more common.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available